Gyre Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $63.3M | $11.8M |
| FY2025 | — | $106.0M | $37.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $63.3M | $11.8M |
| FY2025 | — | $106.0M | $37.1M |